DiscoveRx

NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening.
Financial terms of the deal were not disclosed.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.

By Adam Bonislawski
Two papers published in the current edition of Nature Biotechnology add significantly to the publicly available data on the specificity of kinase inhibitors.

Starting in the first quarter of 2011, DiscoveRx plans to add its own panel of cell-based assays to the KinomeScan service as an offering.

The co-marketing agreement will give Jubilant’s drug developer customers cell-based screening services.

BioFocus will offer DiscoveRx's GPCR and cAMP assays as part of its screening services.

DiscoveRx will provide GSK with access to its beta-arresting parental cell lines, clones, and associated reagents.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.